Parkinson disease: adjunctive entacapone therapy increases risk of dyskinesia

Nat Rev Neurol. 2010 Nov;6(11):590-1. doi: 10.1038/nrneurol.2010.158.
No abstract available

Publication types

  • News

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use*
  • Carbidopa / adverse effects
  • Carbidopa / therapeutic use
  • Catechols / adverse effects
  • Catechols / therapeutic use*
  • Corpus Striatum / drug effects
  • Dopamine / metabolism
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Combinations
  • Drug Therapy, Combination
  • Humans
  • Levodopa / adverse effects
  • Levodopa / therapeutic use
  • Neurologic Examination / drug effects
  • Nitriles / adverse effects
  • Nitriles / therapeutic use*
  • Parkinson Disease / drug therapy*
  • Randomized Controlled Trials as Topic
  • Receptors, Dopamine / drug effects

Substances

  • Antiparkinson Agents
  • Catechols
  • Drug Combinations
  • Nitriles
  • Receptors, Dopamine
  • carbidopa, levodopa drug combination
  • Levodopa
  • entacapone
  • Carbidopa
  • Dopamine